I can extract side effects

A big news suddenly broke the tranquility of the night.

Headline after headline frantically pops up on everyone's phone, all about the same thing.

"The State Food and Drug Administration requires strict investigation into the cancer-causing problem of Sanofi's antihypertensive drugs."

"Sanofi's irbesartan drug was detected with nitrosamines, and was ordered to recall the problematic drug."

"The Food and Drug Administration strikes with an iron fist, forcing the recall of problematic drugs, or imposing heavy fines."

Netizens were dumbfounded when they saw the news.

They are still scolding those double-standard foreign companies on the Internet these days.

I didn't expect the Food and Drug Administration to take a thunderous move in such a short period of time and deal with the double-standard problem of the problematic drug forcefully.

Suddenly feel elated.

Open the hot search and see that the wording of the news is harsh, and the detailed content makes people feel comfortable.

"The CFDA attaches great importance to the detection of nitrosamines in irbesartan tablets, a drug sold globally by Sanofi, a national pharmaceutical company in Gaul, and immediately launched an investigation into Sanofi Huaxia Branch and dealt with it according to law. "

"The Beijing Food and Drug Administration immediately organized personnel to conduct random inspections of the drugs sold by Sanofi. After preliminary investigation and analysis, nitrosamines were detected in the antihypertensive drugs Sanofi sold. caused by a process problem.”

"The China Food and Drug Administration has dealt with this serious safety incident, requiring Sanofi Huaxia Branch to immediately recall the problematic batch of drugs, and deal with related compensation and personnel lawsuits in accordance with the law."

"When all the drugs are recalled, another administrative fine of twenty times the amount involved will be imposed."

"It can be seen from this that any pharmaceutical manufacturer in China must put product quality first and consciously abide by my country's laws and regulations and relevant technical specifications."

"Whenever there is a product defect or quality problem, the company involved must take recall measures, report to the drug regulatory authority, and actively disclose information to the public. All recalled drugs abroad must be simultaneously recalled in China."

"The Food and Drug Administration will further strengthen its supervision, grasp the recall information of drug regulatory agencies in various countries in a timely manner, and will take strict regulatory measures for drug manufacturers who do not report recalls and recalls that are not timely, until they stop producing and selling drugs in China."

Netizens were all shocked when they saw the results of such treatment on the news.

This is the first time that the Food and Drug Administration has made a public and tough statement to pharmaceutical companies in China.

People can see the government's determination to strictly supervise drug safety.

Between the lines, there is a burst of murderous intent.

Netizens were silent for a long time, and after a while, they cheered instantly.

"The Directorate General is wise and well done!"

"Give me back the problematic medicine! Back! Back!"

"Calling you a double standard, if you insist on not recalling it, you will be suppressed by an iron fist, hahaha!"

"Punish! Punish severely! Don't be polite, you must punish until their heart hurts!"

"Is there any problem with other antihypertensive drugs? You have to check it all."

"In the future, you should take Sanqing for the antihypertensive medicine, don't worry about it."

"Support! We must strictly investigate and deal with it in accordance with the law!"

"I just went to the official website of the Food and Drug Administration. In the past year, there have been many recalls of problematic drugs. Most of them are domestic pharmaceutical companies. This time it is finally the turn of foreign companies."

"Since the last Changsheng vaccine accident, the pharmaceutical industry still attaches great importance to the issue of drug safety. No, the official responded immediately."

"I hope other industries can follow suit and take care of these double-standard foreign companies. I remember the double-standard issue of Magnum Ice Cream last time. It seems that there is no further article."

"Then you have to contact the State Administration for Market Regulation. Maybe the double-standard ice cream is not serious. After all, it's just a falsified ingredient list, and it's not killing people. It must be more serious because there are no drugs that cause cancer."

"Hey, I am completely relieved about drug safety now. When will I be able to strike hard at food safety issues so that everyone can eat with more peace of mind?"

"It's hard to say. In this domestic market environment, if there are no problems, we will not learn our lessons."

"If something goes wrong, you won't learn from experience. Pickled cabbage with feet is still being sold. You can only vote with your feet. Just don't buy it."

"That's right, whether it's medicine or food, we must buy conscientious domestic products in the future. If we want to make double-standard foreign companies either cool down, or walk on a cool road."

At the same time, Sanofi officially apologized to the entire network and announced the recall of problematic batches of antihypertensive drugs.

"I'm sorry, I failed everyone's trust. We sincerely apologize to all Chinese people for the mistakes we made."

"We will officially recall all the problematic drugs sold in the Huaxia market. After inspection, the problematic batches are xxxx and xxxx. Please return the patients who bought these batches of drugs to the original hospital immediately, and the payment will be returned to the original route. "

"From now on, we will, in an attitude of being responsible for public health, carefully find out the cause of the problem, improve quality management, implement various risk control measures, eliminate potential safety hazards, and ensure the quality of marketed products."

"If you have any questions, please don't hesitate to contact us as soon as possible to discuss the follow-up method. Thank you!"

This time Sanofi didn't dare to turn off comments anymore, and netizens flocked in, venting their emotions to their heart's content.

"If you are told to be hard-spoken, is it tougher than the people's iron fist?"

"I hope that the government will be so tough in the future and will forcefully suppress double-standard foreign companies."

"This time I am standing at the Food and Drug Administration, @市场监督局, take a good look at how they do it!"

"Learn, @薇瑞, @Johnson \u0026 Johnson, @贝瑞东, @罗尼, @林叶大鹅, @Nike, @二星, @凡物, @大量, @IKEA, @梦龙."

Under this announcement, netizens @ all double-standard foreign companies.

I kept going to their official homepages to brush comments.

For a moment, all the foreign companies looked at this situation, each of them trembling with fear.

While rejoicing that they were not the one who was sacrificed to heaven, they wailed in their hearts.

Is the Chinese market going to change?

Is this the official killing chickens and monkeys?

Will there be a strict investigation if there is a problem in the future?

Thinking of this, all the executives of the Huaxia District of the foreign company felt a chill on their necks, and gusts of cold wind blew past.

*****

After Sanofi was established as a model, the food and drug administration bureaus in various cities began to step up their efforts to conduct random inspections of drugs on sale and detect drug quality problems.

Other pharmaceutical companies have also responded to strengthen the quality control of their own drugs.

All of a sudden, there was turmoil, and the imported drugs in the entire antihypertensive drug market dropped sharply.

Under such circumstances, Sanxin's antihypertensive drugs, which were newly launched, were almost pushed in by a strong force, and instantly filled the market that had suddenly fallen into a vacuum.

The Food and Drug Administration also wanted to understand through Sanofi's matter.

It may be more difficult for pharmaceutical companies to consciously report problems and take the initiative to recall, but it must rely on strengthened supervision and strict punishment to really play a role.

Generally speaking, after a drug has an adverse reaction, the company should conduct a safety evaluation, choose to add a black box to warn the risk, or restrict the use of the population, and if the risk of the drug is greater than the benefit, it needs to be recalled.

The recall should also distinguish between different situations. If there is a problem with the drug formula or medical device, or if the product itself is defective, then all products must be recalled.

And if there is a non-systematic quality problem in a certain production link or transportation link, then only this batch of products needs to be recalled.

Due to the wide variety of drugs, it is impossible for the regulatory authorities to fully grasp the adverse reactions of all drugs in the first place, mainly relying on the active reporting of enterprises.

Adverse drug reaction monitoring is the upstream link of drug recall, and it should play a major role in theory.

Drug recall is the last firewall for drug safety.

In Eagle Country, 60% of adverse drug reaction reports are reported by enterprises, but in China, the opposite is true.

The proportion of adverse drug reaction testing reports of domestic pharmaceutical companies is only 25%.

If the adverse drug reaction information is not reported in time, then the subsequent drug recall link will inevitably be absent.

To ensure drug safety, not only do we need to strengthen supervision, but the company itself must be able to correctly handle the relationship between the interests of the company and the interests of patients.

After this incident, drug safety issues once again aroused the attention of policymakers.

This thunderous move by the Food and Drug Administration undoubtedly showed their attitude and determination.